Helixmith Co., Ltd — Investor Relations & Filings
Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 증권발행결과(자율공시)(제4회차 CB) | 2021-01-22 | Korean | |
| 기타경영사항(특허권취득)(자율공시)(항-c-Met 항체 및 이의 용도(Anti-c-Met antibodies and uses thereof)) | 2021-01-20 | Korean | |
| 주요사항보고서(전환사채권발행결정) | 2021-01-20 | Korean | |
| 전환사채(해외전환사채포함)발행후만기전사채취득(제2회차,제3회차) | 2021-01-18 | Korean | |
| 유상증자최종발행가액확정(주주배정후 실권주 일반공모) | 2020-12-16 | Korean | |
| [기재정정]주요사항보고서(유상증자결정) | 2020-12-16 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
4 filings
| |||||
| 9345146 | 증권발행결과(자율공시)(제4회차 CB) | 2021-01-22 | Korean | ||
| 9347534 | 기타경영사항(특허권취득)(자율공시)(항-c-Met 항체 및 이의 용도(Anti-c-Met antibodies and uses thereof)) | 2021-01-20 | Korean | ||
| 9346808 | 주요사항보고서(전환사채권발행결정) | 2021-01-20 | Korean | ||
| 9349090 | 전환사채(해외전환사채포함)발행후만기전사채취득(제2회차,제3회차) | 2021-01-18 | Korean | ||
|
2020
11 filings
| |||||
| 9360722 | 유상증자최종발행가액확정(주주배정후 실권주 일반공모) | 2020-12-16 | Korean | ||
| 9360706 | [기재정정]주요사항보고서(유상증자결정) | 2020-12-16 | Korean | ||
| 9360686 | [발행조건확정]증권신고서(지분증권) | 2020-12-16 | Korean | ||
| 9360674 | [기재정정]투자설명서 | 2020-12-16 | Korean | ||
| 9362085 | 주주명부폐쇄기간또는기준일설정 | 2020-12-15 | Korean | ||
| 9361209 | [기재정정]증권신고서(지분증권) | 2020-12-15 | Korean | ||
| 9367702 | 주식등의대량보유상황보고서(일반) | 2020-12-09 | Korean | ||
| 9367691 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2020-12-09 | Korean | ||
| 9373695 | [기재정정]증권신고서(지분증권) | 2020-12-01 | Korean | ||
| 9383495 | 주식등의대량보유상황보고서(일반) | 2020-11-19 | Korean | ||
| 9383473 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2020-11-19 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Helixmith Co., Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17145/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17145 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17145 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17145 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17145}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Helixmith Co., Ltd (id: 17145)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.